CTOs on the Move

PureGels Nutraceuticals

www.puregels.com

 
PureGels Nutraceuticals is a Downey, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

EverlyWell

EverlyWell believes that health tests shouldn`t be hard to get – or hard to understand. The EverlyWell experience is simple. You order one of our kits online, you collect your sample from home and return it via pre-paid mail to one of our fully-certified partner laboratories. A board-certified physician in your state will review and validate your results before you get them. EverlyWell provides a complete, easy-to-read results report online in just a few days. Our comprehensive test kits measure key biomarkers through dried blood spot, urine or saliva samples that are collected in the comfort of your home. EverlyWell empowers individuals by providing easy access to health data. We are proud to offer a suite of direct-to-consumer, regulatory-compliant tests…without a lab visit.

Westlake Medical Research

Westlake Medical Research is a Westlake Village, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IVU Inc

IVU Inc is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ContraVir Pharmaceuticals, Inc

ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.

The Schwartz Group

The Schwartz Group is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.